Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Issued: 2022-2025

Historic Shares Issued for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Mar 2025 value amounting to $91,000.

  • Orchestra BioMed Holdings' Shares Issued rose 405.56% to $91,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $15.1 million, marking a year-over-year increase of 6228.87%. This contributed to the annual value of $15.0 million for FY2024, which is 6408.66% up from last year.
  • As of Q1 2025, Orchestra BioMed Holdings' Shares Issued stood at $91,000, which was down 99.39% from $14.8 million recorded in Q3 2024.
  • Over the past 5 years, Orchestra BioMed Holdings' Shares Issued peaked at $14.8 million during Q3 2024, and registered a low of $4,000 during Q3 2022.
  • Moreover, its 3-year median value for Shares Issued was $77,500 (2023), whereas its average is $1.9 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 86.49% in 2023, then surged by 371,050.00% in 2024.
  • Over the past 4 years, Orchestra BioMed Holdings' Shares Issued (Quarterly) stood at $4,000 in 2022, then remained steady at $153,000 in 2023, then skyrocketed by 371,050.00% to $14.8 million in 2024, then skyrocketed by 405.56% to $91,000 in 2025.
  • Its last three reported values are $91,000 in Q1 2025, $14.8 million for Q3 2024, and $171,000 during Q2 2024.